Diagnostics & Prognostics: Journey to Patient Impact

Actions and Detail Panel

Sales Ended

Event Information

Share this event

Date and time



MaRS East Tower, Princess Margaret Cancer Research Tower

4F Rm. 204 (4-204)

101 College Street

Toronto, Ontario M5G 1L7


Event description


UHN's Technology Development & Commercialization invites the UHN Community to join this exciting panel of experts in the diagnostics/prognostics area as they discuss the challenges to and strategies for getting these tests into the market.

Panelists from LifeLabs, Dynacare, Geneseeq Technology, and Bereskin & Parr will discuss the pathway to developing your diagnostics/prognostics towards patient impact.

LIMITED SPACE: Please RSVP on Eventbrite

Light breakfast will be served



Breakfast and networking


Expert panel discussion providing insight on:

• Clinical and commercial requirements for success

• Development and approval

• Industry’s requirements for technology licensing & collaboration

• Patenting landscape



Panelist Biographies:

Xue Wu, Ph.D: Director, Research & Development, Geneseeq Technology Inc.

Geneseeq is a cancer diagnostic company that provides treatment solutions based on the comprehensive systematic analyses of patients' genomic alterations using next generation sequencing (NGS). Currently, Geneseeq has its headquarters in Toronto, Canada and Nanjing, China with more than 400 employees, and has since provided services to 450+ top hospitals, 1600+ oncologists and 60,000+ cancer patients as the leading company of personalized cancer care in China.

Dr. Xue Wu joined Geneseeq Technology Inc. as one of the co-founders in 2014, and is currently the Director of Research & Development of the company.

Dr. Yvan Côté, General Manager, Dynacare Next and Orchid PRO-DNA, Dynacare

Dynacare (formerly Gamma-Dynacare Medical Laboratories) is one of Canada’s largest, most established health solutions companies with a history that spans more than 50 years. Headquartered in Brampton, Ontario, we have operations in Quebec, Ontario, Manitoba, Saskatchewan, Alberta and British Columbia. Dynacare Laboratories provides services like collection and transportation of specimens, accurate testing and prompt reporting of results to patients, healthcare professionals, hospitals, corporate clients and government agencies across Canada; additional services include advanced genetic testing, digital health, corporate wellness programs, mobile testing as well as a number of specialized services for the insurance industry.

Dr. Yvan Côté has been General Manager of Dynacare Next and Orchid PRO-DNA, divisions of Dynacare, since December 2011.

Noel Courage B.Sc. (Biochem.), LL.B., Partner, Bereskin & Parr LLP

Bereskin & Parr LLP is a leading Canadian full service intellectual property law firm serving clients across all industries around the world. Founded in 1965, the firm has grown to be one of the largest IP firms in Canada with offices located in major economic and technology centres. Bereskin & Parr is made up of more than 70 lawyers and patent and trademark agents, many of whom are recognized as leading practitioners in their specialized fields. The firm has established a depth of legal talent and systems to service clients in every aspect of patent, trademark and copyright law and IP litigation. The firm and its award-winning professionals are consistently ranked as the benchmark for IP law in Canada.

Noel Courage is a partner with Bereskin & Parr LLP and member of the Life Sciences practice group and focuses on the patenting and licensing of biotechnological, chemical and mechanical inventions.

Barry Elkind, M.Sc., Ph.D., Senior Manager, Product & Service Innovation, LifeLabs Medical Laboratory Services

LifeLabs has operated in Canada for nearly 50 years and is a leading provider of laboratory testing and management services, contributing to the treatment and prevention of disease by enabling healthcare providers to operate more efficiently and effectively. LifeLabs provides more than 100 million diagnostic tests for approximately 19 million patients visits annually.

Barry is Senior Manager, Product and Service Innovation at LifeLabs and manages new product introductions, from their assessment and business casing through to operational planning. He specializes in molecular diagnostics, with passion for oncology.

Questions? Please contact allison.aab@uhnresearch.ca

Date and time


MaRS East Tower, Princess Margaret Cancer Research Tower

4F Rm. 204 (4-204)

101 College Street

Toronto, Ontario M5G 1L7


Organizer UHN Technology Development & Commercialization (TDC)

Organizer of Diagnostics & Prognostics: Journey to Patient Impact

TDC works with research scientists and clinicians at UHN to create new intellectual property and advance it towards licensing, research and development partnerships, sponsored research agreements, and new company formation. Learn more at tdc.uhnresearch.ca. 

Save This Event

Event Saved